Ramona

Based in the US, Ramona, operates as a developer of microscopy tools for large-area cellular imaging. Based in Durham, the US and founded in 2017, Ramona develops advanced microscopy tools. The funding will be used to scale operations, advance its microscopy platform, expand assays, and strengthen partnerships. Ramona specializes in advanced high-throughput live imaging systems designed to enhance biological research and discovery.

The company’s core product offerings include the Vireo™, Kestrel™, and MCAM™ systems, which leverage proprietary Multi-Camera Array Microscope (MCAM) technology to deliver real-time, high-resolution, 4D imaging and analysis of small model organisms. These systems are optimized for applications that require rapid capture of dynamic biological processes across entire well plates, allowing researchers to conduct comprehensive behavioral, morphological, and fluorescence analysis. Ramona serves a diverse clientele that includes leading biotech companies, pharmaceutical firms, and academic institutions across North America, Europe, and Asia. Ramona generates revenue through the direct sale of its imaging systems and associated software platforms.

The business transaction structure involves B2B partnerships with research institutions and biotech companies, enabling these clients to integrate Ramona's advanced imaging solutions into their laboratories. Customers typically engage in purchasing agreements that can include one-time equipment sales and recurring software licensing for the MCAM™ and its analytical tools. Specific pricing plans for these systems are tailored to the needs of the institutions, ensuring alignment with the scale and scope of their research projects. The company plans to scale operations, advance its microscopy platform, expand assays, and strengthen partnerships following its recent funding.